N-Methyl-N-ethyltryptamine

From WikiMD's WELLNESSPEDIA

N-Methyl-N-ethyltryptamine (NET) is a psychedelic and entheogenic drug that is structurally related to other tryptamine derivatives. It is known for its hallucinogenic effects, which are similar to those of other psychedelic substances such as DMT and psilocybin.

Chemistry[edit]

N-Methyl-N-ethyltryptamine is a member of the tryptamine class of compounds, which are structurally similar to the amino acid tryptophan. It is a derivative of tryptamine with two additional alkyl groups attached to the nitrogen atom, specifically a methyl and an ethyl group. This modification increases the lipophilicity of the molecule, which can enhance its ability to cross the blood-brain barrier and exert its effects in the brain.

Pharmacology[edit]

The exact mechanism of action of N-Methyl-N-ethyltryptamine is not fully understood. However, it is believed to act primarily as a serotonin receptor agonist, similar to other psychedelic tryptamines. This means it binds to and activates these receptors, leading to an increase in serotonin activity in the brain. This increased activity is thought to be responsible for the drug's hallucinogenic effects.

Effects[edit]

The effects of N-Methyl-N-ethyltryptamine can vary widely depending on the dose, the individual's physiology, and the context in which it is used. Common effects reported by users include visual and auditory hallucinations, altered perception of time and space, enhanced introspection, and feelings of euphoria. However, negative effects such as anxiety, paranoia, and physical discomfort can also occur.

Legal Status[edit]

The legal status of N-Methyl-N-ethyltryptamine varies by country. In some jurisdictions, it is classified as a controlled substance and its possession, sale, or use is prohibited. In others, it may be legal for research or therapeutic use under certain conditions.

See Also[edit]



This article is a stub related to chemistry. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.